Learn More
Invitrogen™ ErbB4 (Her4) Monoclonal Antibody (HFR1), eBioscience™, Invitrogen™

Mouse Monoclonal Antibody
£233.00 - £3115.00
Specifications
| Antigen | ErbB4 (Her4) |
|---|---|
| Clone | HFR1 |
| Concentration | 0.5 mg/mL |
| Classification | Monoclonal |
| Conjugate | Unconjugated |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
15547606
![]() |
Invitrogen™
14-9687-80 |
25 μg |
£233.00
25µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
17110752
|
Invitrogen™
14-9687-37 |
2 mg |
£1376.00
2mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
17120752
|
Affymetrix eBioscience
14-9687-95 |
10 mg | |||||||
Description
The MAb HFR1 recognizes human and mouse epidermal growth factor receptor 4 (ErbB4 or HER4). ErbB4 belongs to the family of receptor tyrosine kinases (RTK) of which HER1 (EGRF), HER2 (ErbB2), and HER3 (ErbB3) are members. RTKs function to affect a variety of cell processes including proliferation, differentiation, migration, survival and apoptosis and are often disregulated in cancer. The ErbB4 protein contains extracellular ligand binding domains, a transmembrane region, and a cytoplasmic tail containing the tyrosine kinase domain and the binding site for the HFR1 antibody. Upon ligand binding, ErbB4 homo- or hetero-dimerizes with other family members, becomes phosphorylated, and can be cleaved allowing translocation to the nucleus. The HRF1 antibody recognizes membrane-bound, cytoplasmic and nuclear ErbB4. Cytosolic ErbB4 expression was found to correlate with a positive prognosis in a subset of breast cancer patients, while nuclear ErbB4 expression was inversely correlated with tumor grade and aggressiveness of breast tumors.
Oncogene ERBB4 (HER4) is a member of the type I receptor protein tyrosine subfamily that includes EGFR, ERBB2, and ERBB3. ERBB4 binds and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. ErbB 4 is activated by neuregulins and NTAK (neural and thymus derived activator for ErbB kinases). ErbB 4 is a receptor for heregulin and is capable of mediating HGL-stimulated tyrosine phosphorylation of itself. Like other protein kinases, ErbB 4 mediate most of the signal transduction in eukaryotic cells, regulating cellular metabolism, transcription, cell cycle progression, cytoskeletal rearrangement and cell movement, apoptosis, and differentiation. ErbB 4 is most predominantly expressed in several breast carcinoma cell lines, and in normal skeletal muscle, heart, pituitary, brain, and cerebellum. Breast tumor cell lines T47-D, MDA-MB-453, BT-474 and H3396 are found to have the highest levels of mRNA, and intermediate levels are seen in MCF-7, MDAMB-330 and MDA-MB-361. Expression of ErbB 4 is low or absent in some breast tumor cell lines such as MDA-MB-231, MDA-MB-157, MDA-MB-468, and SKBR-3. ErbB 4 levels have been found to be elevated in certain human tumor cell lines suggesting that it may play a role in some malignancies.Specifications
| ErbB4 (Her4) | |
| 0.5 mg/mL | |
| Unconjugated | |
| Mouse | |
| Human, Mouse | |
| Q15303, Q61527 | |
| IgG2b κ | |
| Affinity Chromatography | |
| Antibody |
| HFR1 | |
| Monoclonal | |
| Liquid | |
| RUO | |
| PBS with 0.09% sodium azide; pH 7.2 | |
| 13869, 2066 | |
| Primary | |
| 4°C | |
| ERBB4 |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.